ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AFFX Stock Price » AFFX Stock News

Affymetrix Share News

 Affymetrix (mm) Stock Price
AFFX Stock Price
 Affymetrix (mm) Stock Chart
AFFX Stock Chart
 Affymetrix (mm) Stock News
AFFX Stock News
 Affymetrix (mm) Company Information
AFFX Company Information
 Affymetrix (mm) Stock Trades
AFFX Stock Trades

H1N1 Test With Affymetrix Technology Gets FDA Approval

DOW JONES NEWSWIRES Affymetrix Inc. (AFFX) and TessArae LLC said the Food and Drug Administration has granted emergency use authorization for a H1N1 influenza detection panel. Shares rose 9.6% premarket to $6.08. The stock has nearly doubled this year. The product was created by privately held TessArae using technology from Affymetrix, which makes products to help analyze genetic information. TessArae's product isn't the only one to receive such emergency clearance from the FDA for H1N1 detection, but the company said one of its product's unique aspects is that it "directly generates genomic sequence from multiple influenza virus genes" to identify the particular H1N1 virus strain in a single test. -By Kevin Kingsbury; Dow Jones Newswires; 212-416-2354;

Stock News for Affymetrix (AFFX)
No Recent News Available

Affymetrix and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations